Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Hexylamine Hydrobromide
2. Hexylamine Hydrochloride
1. 111-26-2
2. Hexan-1-amine
3. N-hexylamine
4. 1-aminohexane
5. 1-hexylamine
6. 1-hexanamine
7. Hexanamine
8. Mono-n-hexylamine
9. Hexyl Amine
10. Chebi:5712
11. Ci4e002zv8
12. Nsc-2590
13. Nsc 2590
14. Einecs 203-851-8
15. Ent 16554
16. Mfcd00008240
17. Brn 1731298
18. Unii-ci4e002zv8
19. Hexyl-amine
20. Pentylmethanamine
21. Ai3-16554
22. N-n-hexylamine
23. N-hexyl Amine
24. Hexane-1-amine
25. Hexyl Amine-1
26. Hexylamine, 99%
27. Hexylamine [fhfi]
28. Dsstox_cid_1930
29. Ec 203-851-8
30. Dsstox_rid_76409
31. Dsstox_gsid_21930
32. Schembl15939
33. N-c6h13nh2
34. Wln: Z6
35. 4-04-00-00709 (beilstein Handbook Reference)
36. Hexylamine, Analytical Standard
37. Chembl1320720
38. Dtxsid3021930
39. Fema No. 4243
40. Hsdb 8444
41. Nsc2590
42. Amy21942
43. Zinc1531059
44. Tox21_200036
45. Bbl011106
46. Stk802350
47. Akos000119866
48. Hexylamine, Purum, >=98.0% (gc)
49. Ncgc00091816-01
50. Ncgc00091816-02
51. Ncgc00257590-01
52. Bp-30167
53. Bp-31178
54. Cas-111-26-2
55. Vs-02837
56. Ft-0607346
57. H0134
58. C08306
59. Q426238
60. J-002548
61. F2191-0288
| Molecular Weight | 101.19 g/mol |
|---|---|
| Molecular Formula | C6H15N |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Exact Mass | 101.120449483 g/mol |
| Monoisotopic Mass | 101.120449483 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 27.4 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
74
PharmaCompass offers a list of Hexylamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hexylamine manufacturer or Hexylamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hexylamine manufacturer or Hexylamine supplier.
PharmaCompass also assists you with knowing the Hexylamine API Price utilized in the formulation of products. Hexylamine API Price is not always fixed or binding as the Hexylamine Price is obtained through a variety of data sources. The Hexylamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A n-C6H13NH2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of n-C6H13NH2, including repackagers and relabelers. The FDA regulates n-C6H13NH2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. n-C6H13NH2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A n-C6H13NH2 supplier is an individual or a company that provides n-C6H13NH2 active pharmaceutical ingredient (API) or n-C6H13NH2 finished formulations upon request. The n-C6H13NH2 suppliers may include n-C6H13NH2 API manufacturers, exporters, distributors and traders.
n-C6H13NH2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of n-C6H13NH2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right n-C6H13NH2 GMP manufacturer or n-C6H13NH2 GMP API supplier for your needs.
A n-C6H13NH2 CoA (Certificate of Analysis) is a formal document that attests to n-C6H13NH2's compliance with n-C6H13NH2 specifications and serves as a tool for batch-level quality control.
n-C6H13NH2 CoA mostly includes findings from lab analyses of a specific batch. For each n-C6H13NH2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
n-C6H13NH2 may be tested according to a variety of international standards, such as European Pharmacopoeia (n-C6H13NH2 EP), n-C6H13NH2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (n-C6H13NH2 USP).
